|
Volumn 29, Issue 7, 2002, Pages 433-437
|
Is vaccination for pneumococci in the over-65s justified?;Está justificada la vacunación contra el neumococo en mayores de 65 años?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PNEUMOCOCCUS VACCINE;
AGING;
CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
DRUG INDICATION;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
HEALTH ECONOMICS;
HUMAN;
META ANALYSIS;
MORTALITY;
REVIEW;
STREPTOCOCCUS INFECTION;
STREPTOCOCCUS PNEUMONIAE;
VACCINATION;
AGE;
AGED;
AGE FACTORS;
AGED;
CLINICAL TRIALS;
HUMANS;
PNEUMOCOCCAL INFECTIONS;
PNEUMOCOCCAL VACCINES;
|
EID: 0012710258
PISSN: 02126567
EISSN: None
Source Type: Journal
DOI: 10.1016/S0212-6567(02)70601-X Document Type: Article |
Times cited : (6)
|
References (27)
|